SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-23-036678
Filing Date
2023-03-24
Accepted
2023-03-24 17:01:34
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm2310116d1_s3.htm S-3 200657
2 EXHIBIT 4.4 tm2310116d1_ex4-4.htm EX-4.4 491685
3 EXHIBIT 5.1 tm2310116d1_ex5-1.htm EX-5.1 31176
4 EXHIBIT 23.1 tm2310116d1_ex23-1.htm EX-23.1 2827
5 EXHIBIT 107 tm2310116d1_ex107.htm EX-FILING FEES 12907
6 GRAPHIC image_001.jpg GRAPHIC 3142
7 GRAPHIC tm2310116d1_s3img01.jpg GRAPHIC 14145
8 GRAPHIC tm2310116d1_s3img02.jpg GRAPHIC 14173
  Complete submission text file 0001104659-23-036678.txt   783992
Mailing Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453
Business Address 95 SAWYER ROAD SUITE 110 WALTHAM MA 02453 781-652-4500
Checkpoint Therapeutics, Inc. (Filer) CIK: 0001651407 (see all company filings)

IRS No.: 472568632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-270843 | Film No.: 23760649
SIC: 2834 Pharmaceutical Preparations